共 62 条
[51]
A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting
[J].
ONCOLOGIST,
2020, 25 (12)
:E1846-E1854
[52]
Survivorship, Version 1.2022 Featured Updates to the NCCN Guidelines
[J].
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK,
2022, 20 (10)
:1080-1090
[54]
Suh-Burgmann B, 2021, OBSTET GYNECOL, V138, P950